Location History:
- Clayton, MO (US) (2006)
- Bothell, WA (US) (2010)
Company Filing History:
Years Active: 2006-2010
Title: Grant Risdon: Innovator in Cancer Treatment
Introduction
Grant Risdon is a notable inventor based in Bothell, Washington, who has made significant contributions to the field of medical treatments, particularly in cancer and autoimmune diseases. With a total of two patents to his name, Risdon's work focuses on innovative methods that aim to improve patient outcomes in challenging medical conditions.
Latest Patents
Risdon's latest patents include groundbreaking methods for treating neoplastic, autoimmune, and inflammatory diseases. One of his key inventions involves methods of treating cancer and autoimmune diseases, providing new avenues for therapeutic interventions. Another significant patent is related to recombinant anti-CD30 antibodies and their uses, specifically targeting Hodgkin's Disease. This invention outlines methods and compositions that utilize proteins capable of binding to CD30, which can exert cytostatic or cytotoxic effects on Hodgkin's Disease cells. The proteins described in this patent can be human, humanized, or chimeric antibodies and may be conjugated to cytotoxic agents such as chemotherapeutic drugs. Additionally, the invention includes nucleic acids encoding these proteins and methods for identifying effective anti-CD30 antibodies for treatment.
Career Highlights
Grant Risdon is currently associated with Seattle Genetics, Inc., a company renowned for its focus on developing innovative cancer therapies. His work at Seattle Genetics has positioned him as a key player in the advancement of targeted treatments for cancer patients.
Collaborations
Some of Risdon's notable coworkers include Alan F Wahl and Jonathan G Drachman, who have also contributed to the field of cancer research and treatment. Their collaborative efforts have further enhanced the impact of their innovations in medical science.
Conclusion
In summary, Grant Risdon is a distinguished inventor whose work in cancer treatment and autoimmune diseases has the potential to transform therapeutic approaches. His patents reflect a commitment to advancing medical science and improving patient care.